基于SH2超亲体的微量样品酪氨酸磷酸化蛋白质组学技术研究进展及应用

酪氨酸磷酸化是生物体内一种重要的蛋白质磷酸化修饰类型,参与细胞信号转导、细胞迁移、凋亡等众多的生命活动过程。在磷酸化蛋白质组学研究中,由于酪氨酸磷酸化蛋白丰度低且有时起始样品量有限,传统的磷酸化蛋白质组富集方法用于酪氨酸磷酸化肽富集效率较低。微量样品的制备技术以及SH2超亲体的引入正在改变酪氨酸磷酸化蛋白质组研究的现状,现对此进行综述。     

用蛋白质组学方法研究蛋白质酪氨酸磷酸化

蛋白质的磷酸化与去磷酸化过程是生物体内普遍存在的信息传导调节方式,几乎涉及所有的生理及病理过程,其中酪氨酸残基的磷酸化作为较高级的进化形式和复杂的多细胞生命的特征表现得尤为突出和重要。但目前对酪氨酸磷酸化缺乏大规模和系统性的研究,近年发展起来的蛋白质组学为细胞和组织中的酪氨酸磷酸化蛋白质的系统研究提供了必要的技术。     

酪氨酸磷酸化在精子获能中的作用

获能是精子发生顶体反应以及与卵子结合之前所必需的生理过程.研究发现在精子获能过程中伴随有蛋白质的磷酸化特别是酪氨酸的磷酸化.主要对酪氨酸磷酸化蛋白在精子获能过程中的作用及其存在的部位进行归纳总结,为进一步阐明精子获能分子机制奠定基础.     

Mtss1抗体制备及小脑中不同亚型磷酸化水平的检测

肿瘤转移抑制蛋白(Metastasis suppressor1,Mtss1),又名肿瘤转移消失蛋白(Missing in metastasis,MIM)在小脑神经元发育中受到调控,依次表达两种亚型:包含Src磷酸化位点的广泛表达亚型;含Src磷酸化位点片段经RNA剪接去除的神经元特异亚型.为检测这两种Mtss1亚型的酪氨酸磷酸化水平是否因Src磷酸化位点的去除存在明显区别,制备了灵敏度较高并可特异性沉淀外源和内源表达的Mtss1的兔多克隆抗体,对发育时期与成年大鼠小脑内源Mtss1酪氨酸磷酸化水平进行检测,发现成年后的Mtss1与出生后发育时期的Mtss1均发生明显的酪氨酸磷酸化,表明剪接去除包含有Src磷酸化位点中的神经元特异亚型中,还有其他的酪氨酸残基被磷酸化,提示其他酪氨酸磷酸化激酶信号通路对Mtss1神经元亚型的调控作用.     

蛋白质磷酸化修饰的研究进展

蛋白质磷酸化是最常见、最重要的一种蛋白质翻译后修饰方式,它参与和调控生物体内的许多生命活动。通过蛋白质的磷酸化与去磷酸化,调控信号转导、基因表达、细胞周期等诸多细胞过程。随着蛋白质组学技术的发展和应用,蛋白质磷酸化的研究越来越受到广泛的重视。我们介绍了蛋白质磷酸化修饰的主要类型与功能、磷酸化蛋白质分析样品的富集及制备、磷酸化蛋白的鉴定及磷酸化位点的预测、蛋白分离后磷酸化蛋白的检测,及蛋白质磷酸化的分子机制,并综述了近年来国内外的主要相关研究进展。     

人胃黏膜上皮细胞与胃癌细胞间酪氨酸磷酸化的比较蛋白质组学研究

比较人正常胃黏膜上皮细胞GES-1与人胃癌细胞SGC-7901间酪氨酸磷酸化蛋白质的差异,筛选差异磷酸化蛋白质分子,为揭示胃癌发生发展的分子机制提供新的理论依据.采用免疫沉淀方法从人胃黏膜上皮细胞GES-1与人胃癌细胞SGC-7901总蛋白质中免疫沉淀出酪氨酸磷酸化蛋白质,用SDS-PAGE和二维凝胶电泳技术分离沉淀出的酪氨酸磷酸化蛋白质,银染,差异蛋白点进行胶内酶解,采用MALDI-TOF/TOF-MS质谱进行差异蛋白质鉴定.结果显示获得了7个差异酪氨酸磷酸化蛋白质,这些蛋白质涉及细胞骨架、细胞调控等.通过比较正常胃黏膜上皮细胞与胃癌细胞内酪氨酸磷酸化蛋白质的差异,筛选获得7个差异酪氨酸磷酸化蛋白质分子,有助于深入研究胃癌发生发展的分子机制,进而为胃癌的早期诊断和防治提供新的理论依据和作用靶标.     

酪氨酸磷酸化蛋白在体外获能豚鼠精子上的分布与表达

为研究豚鼠精子获能过程中蛋白酪氨酸磷酸化的变化规律,将豚鼠精子悬浮于改良的TALP获能培养基中,在5% CO2 孵箱37 ℃培养,以精子与金霉素(CTC) 荧光结合类型为指标评价精子获能状态,用免疫荧光技术和Western blot方法检测酪氨酸磷酸化的蛋白在精子上的分布以及酪氨酸磷酸化水平的变化。结果显示,随着获能的进行,发生蛋白酪氨酸磷酸化的精子占总精子的百分比增加,由未获能前的36％增至获能7h时的92％。酪氨酸磷酸化的蛋白分布变广,由精子头部扩增至精子头部、鞭毛主段和中段。另外,有80,45,40kDa的三种蛋白发生酪氨酸磷酸化,其中40kDa的蛋白酪氨酸磷酸化水平自精子体外培养后呈递增趋势,45kDa的蛋白酪氨酸磷酸化自培养3h后发现并呈递增趋势,而80kDa的蛋白酪氨酸磷酸化水平在精子培养3h时最高,后呈递减趋势。     

获能期间精子蛋白的酪氨酸磷酸化

哺乳动物精了获能是精子与卵子成功受精的前提。蛋白酪氨酸磷酸化对精子获能十分重要。精了获能期蛋白酪氨酸磷酸化程度增高与sAC/cAMP/PKA途径、受体酪氨酸激酶途径和非受体蛋白酪氨酸激酶途径调节有关。获能过程中酪氨酸磷酸化蛋白分布于精子细胞的不同区域,蛋白的酪氨酸磷酸化与精子功能密切相关。     

BCR信号转导研究进展

Ｂ细胞表面抗原受体（ＢＣＲ）与其抗原或其它配体（如ａｎｔｉ－μＭｃＡｂ）的结合启动了Ｂ细胞的活化,ＢＣＲ交联后,首先在其ＩＴＡＭ序列部位发生酪氨酸磷酸化,从而富集并激活Ｓｒｃ家族蛋白质酪氨酸激酶（ＰＴＫ）,进而Ｓｒｃ家族ＰＴＫ将ＳｙｋＰＴＫ等的酪氨酸磷化而活化,使信号传递下去,在此过程中,还有ＦｏｒγＲⅡｂ和ＣＤ２２等分子通过富集蛋白质酪氨酸磷酸酶ＰＴＰＩＣ活化信号进行负调控,本文就此ＢＣＲ信号转     

磷酸化蛋白质组学的新进展及其在肝脏生理和病理机制中的应用

蛋白质磷酸化是最常见的蛋白质翻译后修饰形式。由于蛋白质的磷酸化形式可以被磷酸酶和磷酸激酶进行可逆的调控,所以在众多的生命活动过程中蛋白质的磷酸化修饰起着重要的调控作用,因此对生物体内蛋白质磷酸化修饰的系统研究对于揭示生命科学的奥秘显得十分重要。近年来,随着质谱技术和生物信息学软件以及磷酸化肽段富集方法的发展,利用质谱对生物体内蛋白质磷酸化修饰研究的技术逐渐成熟。肝脏作为人体最重要的代谢和免疫器官,深入研究肝脏细胞内蛋白质磷酸化修饰形式对于理解其功能具有重要指导意义。目前,迅速发展的磷酸化蛋白质组学技术已经被广泛应用到肝脏功能的生物学研究中。这些研究加深了人们对肝脏的生理及病理状态的分子生物学机制的了解。本文综述了当前磷酸化蛋白质组学的研究进展和磷酸化蛋白质组学在肝脏中的研究。     

Proteomic analysis of phosphorylation in cancer

Constitutive activity of kinases is known to be crucial for a tumor to maintain its malignant phenotype, a phenomenon which is often referred to as oncogene addiction. The in-depth analysis of aberrant signaling pathways by the analysis of protein phosphorylation has become feasible through recent advances in proteomics technology. In this article we will review developments in the field of phosphoproteomics and its application in cancer research. The most widely used technologies for the generic enrichment of phosphopeptides are discussed as well as targeted approaches for the analysis of a specific subset of phosphopeptides. Validation experiments of phosphorylation sites using targeted mass spectrometry are also explained. Finally, we will highlight applications of phosphoproteomic technology in cancer research using cell lines and tissue.     

Large‐scale phosphorylation mapping reveals the extent of tyrosine phosphorylation in Arabidopsis

Protein phosphorylation regulates a wide range of cellular processes. Here, we report the proteome‐wide mapping of in vivo phosphorylation sites in Arabidopsis by using complementary phosphopeptide enrichment techniques coupled with high‐accuracy mass spectrometry. Using unfractionated whole cell lysates of Arabidopsis, we identified 2597 phosphopeptides with 2172 high‐confidence, unique phosphorylation sites from 1346 proteins. The distribution of phosphoserine, phosphothreonine, and phosphotyrosine sites was 85.0, 10.7, and 4.3%. Although typical tyrosine‐specific protein kinases are absent in Arabidopsis, the proportion of phosphotyrosines among the phospho‐residues in Arabidopsis is similar to that in humans, where over 90 tyrosine‐specific protein kinases have been identified. In addition, the tyrosine phosphoproteome shows features distinct from those of the serine and threonine phosphoproteomes. Taken together, we highlight the extent and contribution of tyrosine phosphorylation in plants.     

Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways

Protein phosphorylation is a central regulatory mechanism of cell signaling pathways. This highly controlled biochemical process is involved in most cellular functions, and defects in protein kinases and phosphatases have been implicated in many diseases, highlighting the importance of understanding phosphorylation-mediated signaling networks. However, phosphorylation is a transient modification, and phosphorylated proteins are often less abundant. Therefore, the large-scale identification and quantification of phosphoproteins and their phosphorylation sites under different conditions are one of the most interesting and challenging tasks in the field of proteomics. Both 2D gel electrophoresis and liquid chromatography-tandem mass spectrometry serve as key phosphoproteomic technologies in combination with prefractionation, such as enrichment of phosphorylated proteins/peptides. Recently, new possibilities for quantitative phosphoproteomic analysis have been offered by technical advances in sample preparation, enrichment, separation, instrumentation, quantification and informatics. In this article, we present an overview of several strategies for quantitative phosphoproteomics and discuss how phosphoproteomic analysis can help to elucidate signaling pathways that regulate various cellular processes.     

Phosphoproteomics, oncogenic signaling and cancer research

The past 5 years have seen an explosion of phosphoproteomics methods development. In this review, using epidermal growth-factor signaling as a model, we will discuss how phosphoproteomics, along with bioinformatics and computational modeling, have impacted key aspects of oncogenic signaling such as in the temporal fine mapping of phosphorylation events, and the identification of novel tyrosine kinase substrates and phosphorylation sites. We submit that the next decade will see considerable exploitation of phosphoproteomics in cancer research. Such a phenomenon is already happening as exemplified by its use in promoting the understanding of the molecular etiology of cancer and target-directed therapeutics.     

Tyrosine phosphorylation of the human guanylyl cyclase C receptor

Tyrosine phosphorylation events are key components of several cellular signal transduction pathways. This study describes a novel method for identification of substrates for tyrosine kinases. Co-expression of the tyrosine kinase EphB1 with the intracellular domain of guanylyl cyclase C (GCC) inEscherichia coli cells resulted in tyrosine phosphorylation of GCC, indicating that GCC is a potential substrate for tyrosine kinases. Indeed, GCC expressed in mammalian cells is tyrosine phosphorylated, suggesting that tyrosine phosphorylation may play a role in regulation of GCC signalling. This is the first demonstration of tyrosine phosphorylation of any member of the family of membrane-associated guanylyl cyclases.     

Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC)

Identification of phosphorylated proteins remains a difficult task despite technological advances in protein purification methods and mass spectrometry. Here, we report identification of tyrosine-phosphorylated proteins by coupling stable isotope labeling with amino acids in cell culture (SILAC) to mass spectrometry. We labeled HeLa cells with stable isotopes of tyrosine, or, a combination of arginine and lysine to identify tyrosine phosphorylated proteins. This allowed identification of 118 proteins, of which only 45 proteins were previously described as tyrosine-phosphorylated proteins. A total of 42 in vivo tyrosine phosphorylation sites were mapped, including 34 novel ones. We validated the phosphorylation status of a subset of novel proteins including cytoskeleton associated protein 1, breast cancer anti-estrogen resistance 3, chromosome 3 open reading frame 6, WW binding protein 2, Nice-4 and RNA binding motif protein 4. Our strategy can be used to identify potential kinase substrates without prior knowledge of the signaling pathways and can also be applied to profiling to specific kinases in cells. Because of its sensitivity and general applicability, our approach will be useful for investigating signaling pathways in a global fashion and for using phosphoproteomics for functional annotation of genomes.     

Tyrosine phosphorylation of the N-methyl-D-aspartate receptor by exogenous and postsynaptic density-associated Src-family kinases

Phosphorylation of the NMDA receptor by Src-family tyrosine kinases has been implicated in the regulation of receptor function. We have investigated the tyrosine phosphorylation of NMDA receptor subunits NR2A and NR2B by exogenous Src and Fyn and compared this to phosphorylation by tyrosine kinases associated with the postsynaptic density (PSD). Phosphorylation of the receptor by exogenous Src and Fyn was dependent upon initial binding of the kinases to PSDs via their SH2-domains. Src and Fyn phosphorylated similar sites in NR2A and NR2B, tryptic peptide mapping identifying seven and five major tyrosine-phosphorylated peptides derived from NR2A and NR2B, respectively. All five tyrosine phosphorylation sites on NR2B were localized to the C-terminal, cytoplasmic domain. Phosphorylation of NR2B by endogenous PSD tyrosine kinases yielded only three tyrosine-phosphorylated tryptic peptides, two of which corresponded to Src phosphorylation sites, and one of which was novel. Phosphorylation-site specific antibodies identified NR2B Tyr1472 as a phosphorylation site for intrinsic PSD tyrosine kinases. Phosphorylation of this site was inhibited by the Src-family-specific inhibitor PP2. The results identify several potential phosphorylation sites for Src in the NMDA receptor, and indicate that not all of these sites are available for phosphorylation by kinases located within the structural framework of the PSD.